Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Functional Neuromodulation (Canada) a clinical-stage medical device company focused on deep brain stimulation in the fornix for Alzheimer’s, closed a $10.4M Series A financing. Participants include Genesys Capital and Medtronic.

Nevro (Menlo Park, CA) a clinical-stage medical device company focused on neuromodulation for the relief of chronic pain, closed a $58M Series B financing. Participants include Johnson & Johnson Development Corp, Aberdare Ventures, Accuitive Medical Ventures, Bay City Capital, MPM Capital and Three Arch Partners.

Jan Medical (Mountain View, CA) a development-stage medical device company focused on a brain sensing device for the timely determination of ischemic stroke, closed a $3.1M Series A financing. Participants include Brainlab. The 2Q11 OnBioVC Trend Analysis will be published on Tue 6 September. Advertising opportunities are still available. Reach >45,000 high-value targeted life science […]

Neuronetics (Malvern, PA) a commercial-stage medical device company focused on pulsed magnetic field stimulation for non-invasive, non-systemic treatment of depression, closed a $30M Series E financing. Participants include Polaris Venture Partners, Pfizer Venture Investments, Investor Growth Capital, New Leaf Venture Partners, Interwest Partners, Three Arch Partners, Quaker BioVentures and Onset Ventures.

Neuronetics (Malvern, PA) a commercial-stage medical device company focused on transcranial magnetic neuromodulation for psychiatric and neurological disorders, closed a $36M Series D financing. Participants include New Leaf Venture Partners, Investor Growth Capital, Quaker BioVentures, Three Arch Partners, Onset Ventures, Interwest Partners and KBL Healthcare Ventures.

  

to top of page...